Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues

Carrie E. Johnson, Yolanda Y. Huang, Amanda B. Parrish, Michelle I. Smith, Allyson E. Vaughn, Qian Zhang, Kevin Wright, Terry Van Dyke, Robert J. Wechsler-Reya, Sally Kornbluth, Mohanish Deshmukh

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Brain tumors are typically resistant to conventional chemotherapeutics, most of which initiate apoptosis upstream of mitochondrial cytochrome c release. In this study, we demonstrate that directly activating apoptosis downstream of the mitochondria, with cytosolic cytochrome c, kills brain tumor cells but not normal brain tissue. Specifically, cytosolic cytochrome c is sufficient to induce apoptosis in glioblastoma and medulloblastoma cell lines. In contrast, primary neurons from the cerebellum and cortex are remarkably resistant to cytosolic cytochrome c. Importantly, tumor tissue from mouse models of both high-grade astrocytoma and medulloblastoma display hypersensitivity to cytochrome c when compared with surrounding brain tissue. This differential sensitivity to cytochrome c is attributed to high Apaf-1 levels in the tumor tissue compared with low Apaf-1 levels in the adjacent brain tissue. These differences in Apaf-1 abundance correlate with differences in the levels of E2F1, a previously identified activator of Apaf-1 transcription. ChIP assays reveal that E2F1 binds the Apaf-1 promoter specifically in tumor tissue, suggesting that E2F1 contributes to the expression of Apaf-1 in brain tumors. Together, these results demonstrate an unexpected sensitivity of brain tumors to postmitochondrial induction of apoptosis. Moreover, they raise the possibility that this phenomenon could be exploited therapeutically to selectively kill brain cancer cells while sparing the surrounding brain parenchyma.

Original languageEnglish (US)
Pages (from-to)20820-20825
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume104
Issue number52
DOIs
StatePublished - Dec 26 2007
Externally publishedYes

Fingerprint

Cytochromes c
Brain Neoplasms
Apoptosis
Medulloblastoma
Brain
Neoplasms
Astrocytoma
Glioblastoma
Cerebellum
Mitochondria
Hypersensitivity
Neurons
Cell Line

Keywords

  • Astrocytoma
  • Caspase
  • Cell death
  • Medulloblastoma
  • Neurons

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. / Johnson, Carrie E.; Huang, Yolanda Y.; Parrish, Amanda B.; Smith, Michelle I.; Vaughn, Allyson E.; Zhang, Qian; Wright, Kevin; Van Dyke, Terry; Wechsler-Reya, Robert J.; Kornbluth, Sally; Deshmukh, Mohanish.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 52, 26.12.2007, p. 20820-20825.

Research output: Contribution to journalArticle

Johnson, CE, Huang, YY, Parrish, AB, Smith, MI, Vaughn, AE, Zhang, Q, Wright, K, Van Dyke, T, Wechsler-Reya, RJ, Kornbluth, S & Deshmukh, M 2007, 'Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues', Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 52, pp. 20820-20825. https://doi.org/10.1073/pnas.0709101105
Johnson, Carrie E. ; Huang, Yolanda Y. ; Parrish, Amanda B. ; Smith, Michelle I. ; Vaughn, Allyson E. ; Zhang, Qian ; Wright, Kevin ; Van Dyke, Terry ; Wechsler-Reya, Robert J. ; Kornbluth, Sally ; Deshmukh, Mohanish. / Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. In: Proceedings of the National Academy of Sciences of the United States of America. 2007 ; Vol. 104, No. 52. pp. 20820-20825.
@article{9ff82a8736e147ee9f4672e2135ffe1a,
title = "Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues",
abstract = "Brain tumors are typically resistant to conventional chemotherapeutics, most of which initiate apoptosis upstream of mitochondrial cytochrome c release. In this study, we demonstrate that directly activating apoptosis downstream of the mitochondria, with cytosolic cytochrome c, kills brain tumor cells but not normal brain tissue. Specifically, cytosolic cytochrome c is sufficient to induce apoptosis in glioblastoma and medulloblastoma cell lines. In contrast, primary neurons from the cerebellum and cortex are remarkably resistant to cytosolic cytochrome c. Importantly, tumor tissue from mouse models of both high-grade astrocytoma and medulloblastoma display hypersensitivity to cytochrome c when compared with surrounding brain tissue. This differential sensitivity to cytochrome c is attributed to high Apaf-1 levels in the tumor tissue compared with low Apaf-1 levels in the adjacent brain tissue. These differences in Apaf-1 abundance correlate with differences in the levels of E2F1, a previously identified activator of Apaf-1 transcription. ChIP assays reveal that E2F1 binds the Apaf-1 promoter specifically in tumor tissue, suggesting that E2F1 contributes to the expression of Apaf-1 in brain tumors. Together, these results demonstrate an unexpected sensitivity of brain tumors to postmitochondrial induction of apoptosis. Moreover, they raise the possibility that this phenomenon could be exploited therapeutically to selectively kill brain cancer cells while sparing the surrounding brain parenchyma.",
keywords = "Astrocytoma, Caspase, Cell death, Medulloblastoma, Neurons",
author = "Johnson, {Carrie E.} and Huang, {Yolanda Y.} and Parrish, {Amanda B.} and Smith, {Michelle I.} and Vaughn, {Allyson E.} and Qian Zhang and Kevin Wright and {Van Dyke}, Terry and Wechsler-Reya, {Robert J.} and Sally Kornbluth and Mohanish Deshmukh",
year = "2007",
month = "12",
day = "26",
doi = "10.1073/pnas.0709101105",
language = "English (US)",
volume = "104",
pages = "20820--20825",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "52",

}

TY - JOUR

T1 - Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues

AU - Johnson, Carrie E.

AU - Huang, Yolanda Y.

AU - Parrish, Amanda B.

AU - Smith, Michelle I.

AU - Vaughn, Allyson E.

AU - Zhang, Qian

AU - Wright, Kevin

AU - Van Dyke, Terry

AU - Wechsler-Reya, Robert J.

AU - Kornbluth, Sally

AU - Deshmukh, Mohanish

PY - 2007/12/26

Y1 - 2007/12/26

N2 - Brain tumors are typically resistant to conventional chemotherapeutics, most of which initiate apoptosis upstream of mitochondrial cytochrome c release. In this study, we demonstrate that directly activating apoptosis downstream of the mitochondria, with cytosolic cytochrome c, kills brain tumor cells but not normal brain tissue. Specifically, cytosolic cytochrome c is sufficient to induce apoptosis in glioblastoma and medulloblastoma cell lines. In contrast, primary neurons from the cerebellum and cortex are remarkably resistant to cytosolic cytochrome c. Importantly, tumor tissue from mouse models of both high-grade astrocytoma and medulloblastoma display hypersensitivity to cytochrome c when compared with surrounding brain tissue. This differential sensitivity to cytochrome c is attributed to high Apaf-1 levels in the tumor tissue compared with low Apaf-1 levels in the adjacent brain tissue. These differences in Apaf-1 abundance correlate with differences in the levels of E2F1, a previously identified activator of Apaf-1 transcription. ChIP assays reveal that E2F1 binds the Apaf-1 promoter specifically in tumor tissue, suggesting that E2F1 contributes to the expression of Apaf-1 in brain tumors. Together, these results demonstrate an unexpected sensitivity of brain tumors to postmitochondrial induction of apoptosis. Moreover, they raise the possibility that this phenomenon could be exploited therapeutically to selectively kill brain cancer cells while sparing the surrounding brain parenchyma.

AB - Brain tumors are typically resistant to conventional chemotherapeutics, most of which initiate apoptosis upstream of mitochondrial cytochrome c release. In this study, we demonstrate that directly activating apoptosis downstream of the mitochondria, with cytosolic cytochrome c, kills brain tumor cells but not normal brain tissue. Specifically, cytosolic cytochrome c is sufficient to induce apoptosis in glioblastoma and medulloblastoma cell lines. In contrast, primary neurons from the cerebellum and cortex are remarkably resistant to cytosolic cytochrome c. Importantly, tumor tissue from mouse models of both high-grade astrocytoma and medulloblastoma display hypersensitivity to cytochrome c when compared with surrounding brain tissue. This differential sensitivity to cytochrome c is attributed to high Apaf-1 levels in the tumor tissue compared with low Apaf-1 levels in the adjacent brain tissue. These differences in Apaf-1 abundance correlate with differences in the levels of E2F1, a previously identified activator of Apaf-1 transcription. ChIP assays reveal that E2F1 binds the Apaf-1 promoter specifically in tumor tissue, suggesting that E2F1 contributes to the expression of Apaf-1 in brain tumors. Together, these results demonstrate an unexpected sensitivity of brain tumors to postmitochondrial induction of apoptosis. Moreover, they raise the possibility that this phenomenon could be exploited therapeutically to selectively kill brain cancer cells while sparing the surrounding brain parenchyma.

KW - Astrocytoma

KW - Caspase

KW - Cell death

KW - Medulloblastoma

KW - Neurons

UR - http://www.scopus.com/inward/record.url?scp=38049136542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049136542&partnerID=8YFLogxK

U2 - 10.1073/pnas.0709101105

DO - 10.1073/pnas.0709101105

M3 - Article

VL - 104

SP - 20820

EP - 20825

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 52

ER -